Clinical and Economic Assessment of Medication Adherence Programs in Hypertensive Patients
Keywords:
Hypertension, Medication Adherence, Clinical Outcomes, Cost-Effectiveness, Healthcare Economics, Patient ComplianceAbstract
Abstract BackgroundHypertension is one of the most prevalent chronic diseases worldwide and a major risk factor for cardiovascular morbidity and mortality. Poor medication adherence among hypertensive patients contributes significantly to uncontrolled blood pressure, increased hospital admissions, and higher healthcare costs.
ObjectiveThis study aims to evaluate the clinical effectiveness and economic impact of medication adherence programs among hypertensive patients.
MethodsA prospective observational study was conducted among hypertensive patients enrolled in a structured medication adherence program. Clinical outcomes, including blood pressure control and hospitalization rates, were assessed over a 12-month period. Economic outcomes such as medication costs, healthcare utilization, and cost-effectiveness were also analyzed.
ResultsPatients participating in the adherence program demonstrated improved medication compliance, significant reductions in systolic and diastolic blood pressure, and fewer hypertension-related hospitalizations. Economic analysis indicated lower healthcare expenditures and improved cost-effectiveness compared with standard care.
ConclusionMedication adherence programs significantly improve clinical outcomes and reduce healthcare costs among hypertensive patients, supporting their integration into routine hypertension management.
References
1. Bosworth, H. B., Granger, B. B., Mendys, P., Brindis, R., Burkholder, R., Czajkowski, S. M., Daniel, J. G., Ekman, I., Ho, M., Johnson, M., Kimmel, S., Liu, L. Z., Musaus, J., Shrank, W., Whalley Buono, E., & Weiss, K. (2011). Medication adherence: A call for action. American Heart Journal, 162(3), 412–424. https://doi.org/10.1016/j.ahj.2011.06.007
2. Burnier, M., & Egan, B. M. (2019). Adherence in hypertension. Circulation Research, 124(7), 1124–1140. https://doi.org/10.1161/CIRCRESAHA.118.313220
3. Sabaté, E. (2003). Adherence to long-term therapies: Evidence for action. World Health Organization.
4. Vrijens, B., Vincze, G., Kristanto, P., Urquhart, J., & Burnier, M. (2008). Adherence to prescribed antihypertensive drug treatments. Journal of Hypertension, 26(1), 210–216. https://doi.org/10.1097/HJH.0b013e3282f18f51
5. Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Wright, J. T. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension, 71(6), e13–e115. https://doi.org/10.1161/HYP.0000000000000065
6. Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in cardiovascular outcomes. Circulation, 119(23), 3028–3035. https://doi.org/10.1161/CIRCULATIONAHA.108.768986
7. Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353(5), 487–497. https://doi.org/10.1056/NEJMra050100
8. Krousel-Wood, M., Thomas, S., Muntner, P., & Morisky, D. (2004). Medication adherence: A key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Current Opinion in Cardiology, 19(4), 357–362.
9. Jimmy, B., & Jose, J. (2011). Patient medication adherence: Measures in daily practice. Oman Medical Journal, 26(3), 155–159. https://doi.org/10.5001/omj.2011.38
10. Gajula, S., & Margam, M. (2026, February). A Secure and Scalable Cloud-Based Banking Service Model Leveraging AI and Advanced Cyber Security. In 2026 IEEE 5th International Conference on AI in Cybersecurity (ICAIC) (pp. 1-5). IEEE.
11. Choudhry, N. K., Denberg, T. D., Qaseem, A., & Clinical Guidelines Committee of the American College of Physicians. (2016). Improving adherence to therapy and clinical outcomes while containing costs. Annals of Internal Medicine, 164(6), 425–431.
12. Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018). Economic impact of medication non-adherence by disease groups: A systematic review. BMJ Open, 8(1), e016982. https://doi.org/10.1136/bmjopen-2017-016982
13. Iuga, A. O., & McGuire, M. J. (2014). Adherence and health care costs. Risk Management and Healthcare Policy, 7, 35–44. https://doi.org/10.2147/RMHP.S19801
14. Brown, M. T., & Bussell, J. K. (2011). Medication adherence: WHO cares? Mayo Clinic Proceedings, 86(4), 304–314. https://doi.org/10.4065/mcp.2010.0575
15. Conn, V. S., Ruppar, T. M., Chase, J. D., Enriquez, M., & Cooper, P. S. (2015). Interventions to improve medication adherence in hypertensive patients: Systematic review and meta-analysis. Current Hypertension Reports, 17(12), 94.
16. Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., & Haynes, R. B. (2014). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, 11, CD000011.
17. Gajula, S. (2026, March). Two Pillars of Banking Intelligence: A Comparative Analysis of AI Techniques for Fraud Prevention and Churn Mitigation. In 2026 14th International Symposium on Digital Forensics and Security (ISDFS) (pp. 1-6). IEEE.
18. Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of Clinical Hypertension, 10(5), 348–354.
19. Kripalani, S., Yao, X., & Haynes, R. B. (2007). Interventions to enhance medication adherence in chronic medical conditions. Archives of Internal Medicine, 167(6), 540–550.
20. Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C., Coker-Schwimmer, E. J., Rosen, D. L., Sista, P., & Lohr, K. N. (2012). Interventions to improve adherence to self-administered medications. Annals of Internal Medicine, 157(11), 785–795.
21. Rasmussen, J. N., Chong, A., & Alter, D. A. (2007). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA, 297(2), 177–186. https://doi.org/10.1001/jama.297.2.177
22. World Health Organization. (2023). Hypertension fact sheet. World Health Organization. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
